Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,125 GBX | +0.81% | -1.42% | +14.36% |
May. 30 | Goldman Sachs Starts AstraZeneca With Buy Rating, $97 Price Target | MT |
May. 30 | Goldman Sachs Kicks Off AstraZeneca Coverage at Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.36% | 238B | |
+39.82% | 734B | |
+33.06% | 591B | |
-7.31% | 350B | |
+14.23% | 315B | |
+0.86% | 276B | |
+9.24% | 206B | |
-6.09% | 204B | |
+4.51% | 161B | |
-2.05% | 160B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study